Updated: Jan 21
Karen Jagoda, of Empowered Patient Podcasts in conversation with Joško Bobanović, a Partner, Industrial Biotechnology funds at Sofinnova Partners, a leading European venture capital firm in the life sciences.
The focus of this group is finding companies that are applying the mature tools that were initially developed for healthcare into industrial disciplines, specifically, applications in food, chemicals, agriculture, and materials.
Joško explains, "In the 20 years from then to now, we have shaved multiple zeros from the cost of sequencing. That's equally true for other areas of biotechnology. That shift has allowed us to open up the application from what we tend to call red biotech, red coming from the blood, in terms of healthcare, to other angles of biotech."
"They often come in color-coded. You have the white biotech, green biotech, and blue biotech. The white one is industrial applications or products that are produced in the chemical industry. Then you have the green biotech, which focuses on and deals with plants. Then you have the blue biotech, which is oriented towards the ocean and typically focuses on algae and similar things. That's kind of how we look at biotech opportunities beyond just healthcare."